FDA tells Purell to stop claiming it can prevent flu

Marketing campaign also claims product can prevent ebola spread


The Food and Drug Administration (FDA) told the maker of Purell to discontinue marketing campaigns that includes claims for avoiding flu and ebola, according to an article on The New York Times website.

The campaigns also claim the product can prevent spread of MRSA and norovirus.

The FDA told Gojo Industries that its claims that Purell could reduce the potential for infection or prevent illnesses violated the Federal Food, Drug and Cosmetic Act. 

The agency said it was reclassifying Purell as an unapproved drug, rather than an over-the-counter product.

Read the article.



February 10, 2020


Topic Area: Infection Control

Recent Posts

Emergency Preparedness: Building a Stronger Community

Professional memberships offer a convenient way to access practical resources, stay current on critical changes and learn from peers.

Ground Broken on Lavine Bekenstein Cancer Hospital in Massachusetts

The 450,000-square-foot facility will feature 300 inpatient beds across ten floors and has been designed specifically around the needs of people with cancer and their families.

Camden-on-Gauley Medical Center Reports Data Security Incident

They are conducting a full review of the affected files to determine what information related to their patients, if any, was contained within.

Elevating EVS Professionals: The Case for Certified Hygiene Specialists

Workers cleaning patient rooms are not simply improving appearance. They are reducing bioburden and protecting human health.

Global Handwashing Day and the Importance of Well-Maintained Restrooms

A recent handwashing survey found that Americans value clean restrooms and touchless fixtures.

 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.